World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
43625
World Ranking
9526
National Ranking
4910

Edward Gabrielson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edward Gabrielson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 272 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Edward Gabrielson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edward Gabrielson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Edward Gabrielson is affiliated with the Johns Hopkins University School of Medicine in the United States. Their primary research focus spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions particularly in Oncology, Molecular Biology, and Cancer Research. Additional subfields of focus include Pulmonary and Respiratory Medicine as well as Radiology, Nuclear Medicine and Imaging.

Their research covers several main topics, highlighting areas such as Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations, and Cancer Genomics and Diagnostics. They also work on Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, and the interplay between Cancer, Hypoxia, and Metabolism.

Among the recent notable publications authored by Edward Gabrielson are:

  • NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes, 2020, Clinical Cancer Research
  • Association between pathologic response and survival after neoadjuvant therapy in lung cancer, 2023, Nature Medicine
  • Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cells, 2022, Cell Death and Disease
  • Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics, 2021, Proceedings of the National Academy of Sciences
  • DNA methylation markers predict recurrence-free interval in triple-negative breast cancer, 2020, npj Breast Cancer

Frequent coauthors collaborating with Edward Gabrielson include:

  • Akhilesh Mishra
  • Sridhar Nimmagadda
  • Ashley Cimino-Mathews
  • Patrick M. Forde
  • Dhiraj Kumar

Preferred publication venues for their research comprise Cancer Research, Clinical Cancer Research, Oncogene, Nature Medicine, and Cell Death and Disease.

Best Publications

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

    Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger

  • 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

    Adrian Merlo;James G. Herman;Li Mao;Daniel J. Lee

  • Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

    Patrick M. Forde;Jamie E. Chaft;Kellie N. Smith;Valsamo Anagnostou

  • Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors

    Manel Esteller;Jose Maria Silva;Gemma Dominguez;Felix Bonilla

  • Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

    Steven A. Belinsky;Kristen J. Nikula;William A. Palmisano;Ruth Michels

  • Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.

    Anju Singh;Vikas Misra;Rajesh K Thimmulappa;Hannah Lee

  • Multiple-laboratory comparison of microarray platforms

    Rafael A Irizarry;Daniel Warren;Forrest Spencer;Irene F Kim

  • A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

    Hiromu Suzuki;Edward Gabrielson;Edward Gabrielson;Wei Chen;Wei Chen;Ramaswamy Anbazhagan;Ramaswamy Anbazhagan

  • Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program

    Kevin J. Cheung;Edward Gabrielson;Zena Werb;Andrew J. Ewald

  • Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

    P. Cairns;T. J. Polascik;Y. Eby;K. Tokino

  • Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

    Valsamo Anagnostou;Kellie N. Smith;Patrick M. Forde;Noushin Niknafs

  • DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer

    Malcolm V. Brock;Craig M. Hooker;Emi Ota-Machida;Yu Han

  • Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.

    Lais Osmani;Frederic Askin;Edward Gabrielson;Qing Kay Li

  • Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.

    Christopher M. Heaphy;Andrea P. Subhawong;Seung Mo Hong;Michael G. Goggins

  • Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression

    Jeremy R. Graff;Edward Gabrielson;Hiraoki Fujii;Stephen B. Baylin

  • Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors

    Anju Singh;Sreedhar Venkannagari;Kyu H. Oh;Ya Qin Zhang

  • Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

    Livia Casciola-Rosen;Kanneboyina Nagaraju;Paul Plotz;Kondi Wang

  • Inactivation of Glutathione S-Transferase P1 Gene by Promoter Hypermethylation in Human Neoplasia

    Manel Esteller;Paul G. Corn;Jesus M. Urena;Edward Gabrielson

  • High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung Cancer

    Roy M. Bremnes;R. Veve;E. Gabrielson;F. R. Hirsch

  • Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis (p16 methylationysputumyNNKysquamous cell carcinoma)

    Steven A. Belinsky;K Risten J. Nikula;William A. Palmisano;Ruth Michels

Frequent Co-Authors

Stephen B. Baylin
Stephen B. Baylin Johns Hopkins University
James G. Herman
James G. Herman University of Pittsburgh
Saraswati Sukumar
Saraswati Sukumar Johns Hopkins University School of Medicine
Julie R. Brahmer
Julie R. Brahmer Johns Hopkins University
Hui Zhang
Hui Zhang Johns Hopkins University
Vered Stearns
Vered Stearns Johns Hopkins University
Shyam Biswal
Shyam Biswal Johns Hopkins University
David Sidransky
David Sidransky Johns Hopkins University School of Medicine
Curtis C. Harris
Curtis C. Harris National Institutes of Health
Matthew D. Hellmann
Matthew D. Hellmann Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in careers related to medicine, a range of online degrees and pathways offer flexibility and affordability. Beyond an MD, health professionals can find accelerated options and specialized programs online that cater to diverse interests.

If you're interested in mental health and wish to serve as a nurse practitioner, consider the fastest pmhnp program options available online. These programs can help you quickly gain advanced credentials in psychiatric care.

For those with an interest in healthcare leadership or hospital management, an online health management degree could open doors to administrative roles. Comprehensive training in healthcare policy, planning, and leadership is also accessible through online mha programs affordable for various budgets.

If your goal is advanced clinical practice or leadership, consider a Doctor of Nursing Practice (DNP). Explore the best online dnp programs for a flexible pathway to the highest level of nursing practice.

Best Scientists Citing Edward Gabrielson

Trending Scientists

Recently Published Articles